Tempus AI, Inc. (NASDAQ:TEM) is Green Alpha Advisors LLC's 9th Largest Position

Green Alpha Advisors LLC lifted its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 57.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 50,911 shares of the company's stock after buying an additional 18,628 shares during the period. Tempus AI comprises about 2.6% of Green Alpha Advisors LLC's portfolio, making the stock its 9th biggest holding. Green Alpha Advisors LLC's holdings in Tempus AI were worth $2,456,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. ARK Investment Management LLC increased its holdings in Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after purchasing an additional 3,141,487 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its holdings in Tempus AI by 166.0% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after purchasing an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. grew its position in shares of Tempus AI by 166.0% in the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. grew its position in shares of Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after buying an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Tempus AI by 86,947.2% in the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after buying an additional 1,651,996 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company's stock.

Analysts Set New Price Targets

TEM has been the topic of a number of analyst reports. BTIG Research initiated coverage on Tempus AI in a research report on Monday, April 21st. They issued a "buy" rating and a $60.00 price target on the stock. TD Cowen reiterated a "buy" rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Bank of America upped their price target on Tempus AI from $48.00 to $68.00 and gave the company a "neutral" rating in a research report on Tuesday, May 20th. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a research report on Wednesday, May 7th. Finally, Wolfe Research lowered Tempus AI from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $63.42.

Insider Buying and Selling

In other news, EVP Andrew Polovin sold 13,135 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total value of $603,947.30. Following the completion of the sale, the executive vice president now directly owns 154,171 shares of the company's stock, valued at $7,088,782.58. This represents a 7.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO James William Rogers sold 23,121 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $63.27, for a total value of $1,462,865.67. Following the completion of the sale, the chief financial officer now directly owns 146,001 shares of the company's stock, valued at approximately $9,237,483.27. This trade represents a 13.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 723,042 shares of company stock valued at $37,642,690. 27.60% of the stock is owned by company insiders.

Tempus AI Stock Up 15.0%

TEM stock traded up $8.29 during trading on Monday, reaching $63.47. 31,405,624 shares of the stock were exchanged, compared to its average volume of 6,779,583. The firm's 50 day moving average is $52.07 and its 200 day moving average is $51.75. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The firm has a market cap of $10.99 billion and a P/E ratio of -8.14.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. The firm's quarterly revenue was up 75.4% on a year-over-year basis. As a group, research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.